[18F]ACI-15916 PET in α-synucleinopathies

Clinical trial NCT06891703 · RECRUITING

Trial details

NCT number: NCT06891703
Sponsor: AC Immune SA
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Parkinson's Disease (PD)Multiple System Atrophy (MSA)Dementia With Lewy Bodies (DLB)

Start date: 2025-03-20
Primary completion: 2026-03-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.